Français📈 See the interactive version (live chart) →
For Brown–Forman, we replayed every analyst price target of the past 12 months and measured the real outcome: 37% were profitable, average return +3% (41 calls). At 3 months: +0% average return (29% profitable). The higher the %, the more often analysts were right on this stock.
Their past track record on this stock (targets replayed against real prices) — not a forecast of what will happen.
| Analyst / broker | Calls i | % profitable i | Avg return i |
|---|---|---|---|
| Barclays | 9 | 0% | -21% |
Is Brown–Forman overvalued, and is it a good time to buy Brown–Forman right now? If you're wondering, here's a recap to make up your own mind: Brown–Forman's valuation vs its sector median, to weigh alongside analyst reliability (above) and past performance. Educational information, not buy advice.
The P/E (price ÷ earnings per share) = how many years of earnings you pay for the stock. The higher it is, the more growth the market expects — but the pricier the stock, so more vulnerable if growth disappoints. The forward P/E uses next year's expected earnings: lower than the current P/E = rising expected earnings. We compare it to the sector median to see whether the stock is expensive relative to its peers.
| Metric | Brown–Forman | Sector median (Consumer Staples) |
|---|---|---|
| P/E | 18.3 | 24.4 |
| Forward P/E | 16.1 | 15.6 |
| Net margin | 18% | 7% |
👉 Brown–Forman trades below its sector median (18.3 vs 24.4) — potentially undervalued, or lower expected growth.
📖 P/E, PEG, margin…: see the glossary
💵 Dividend : Brown–Forman pays about $0.92/share/yr → 3.56% yield. what is this?
The analyst consensus on Brown–Forman (BF-B) is "Hold" (6 bullish, 7 bearish calls over 12 months). This is not advice: historically, 37% of their targets on this stock turned out profitable over 1 year.
The median 12-month price target is $27.00 (-1% vs $27.28), ranging from $20.00 to $30.00 (9 analysts).
Over 1 year, 37% of analyst targets on Brown–Forman were profitable, for an average return of +3% (across 41 timestamped calls). This is JPI Invest's accuracy metric.
Analysts target a median of $27.00 within 12 months, i.e. -1% vs the current price. The most bullish targets $30.00, the most cautious $20.00.
Note: analyst targets are 12-month (median $27.00, -1%), NOT 2030. No reliable 5-10 year price forecast exists (« 2030 prediction » models are speculative). The most useful inputs: the 12-month median above, these analysts' historical accuracy (37%), and the stock's past trajectory.
Its P/E is 18.3, forward P/E 16.1. A forward P/E lower than the current P/E means earnings are expected to grow.
📊 See the full interactive analysis of Brown–Forman →
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best — on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
⚠️ Educational information, not investment advice. Analyst price targets are 12-month and can be wrong. Data via Yahoo Finance, recomputed by JPI Invest.